Package Insert: Information for the User
Rabeprazol Combix 20 mg gastro-resistant tablets EFG
Rabeprazol sodium
Read this package insert carefully before starting to take this medicine, as it contains important information for you
Rabeprazol Combix 20 mg contains the active ingredient rabeprazol sodium. Rabeprazol Combix belongs to a class of medicines known as “Proton Pump Inhibitors” (PPIs), which act by reducing the amount of acid produced by the stomach.
Rabeprazol Combix tablets are used for the treatment of:
Do not take Rabeprazol Combix 20 mg
Do not take Rabeprazol Combix if you are in any of the above situations. If you are unsure, consult your doctor or pharmacist before taking Rabeprazol Combix.
See also the Pregnancy and breastfeeding section.
Warnings and precautions
Consult your doctor or pharmacist before taking Rabeprazol Combix:
If you suffer from a skin rash, especially in sun-exposed areas, consult your doctor as soon as possible, as it may be necessary to interrupt treatment with Rabeprazol Combix. Remember to mention any other symptoms you may notice, such as joint pain.
If you are unsure about the above, consult your doctor or pharmacist before taking Rabeprazol Combix.
If you experience severe diarrhea (watery or bloody) with symptoms such as fever, abdominal pain, or sensitivity, stop taking Rabeprazol Combix and see your doctor immediately.
Children
Should not be administered to children.
Rabeprazol Combix interaction with other medications
Inform your doctor or pharmacist if you are taking or have recently taken other medications, including over-the-counter medications and herbal supplements.
In particular, inform your doctor or pharmacist if you are taking any of the following medications:
If you are unsure about the above, consult your doctor or pharmacist before taking Rabeprazol Combix.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machines
You may feel drowsiness while taking Rabeprazol Combix. If this occurs, do not drive or operate tools or machines.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor again.
Taking this medication
Adults and elderly patients
For gastroesophageal reflux disease (GERD)
Moderate to severe symptom treatment (GERD symptomatic)
Severe symptom treatment (GERD erosive or ulcerative)
Maintenance treatment of symptoms (GERD maintenance)
For stomach ulcers (peptic ulcers)
For duodenal ulcers
For ulcers caused by H. Pylori infection and to prevent recurrences
For more information on other medications used to treatH. pylori, read the prospectus for each one.
Zollinger-Ellison syndrome, where excess acid is produced in the stomach
Use in children
This medication should not be given to children.
Patients with liver problems
Consult your doctor, who will have special care in the initiation and during treatment with Rabeprazol Combix.
If you take more Rabeprazol Combix than you should
If you take more Rabeprazol Combix than you should, talk to your doctor or go to the hospital immediately. Bring the medication with you.
In case of overdose or accidental ingestion, consult the Toxicological Information Service (Telephone: 91 5620420)
If you forget to take Rabeprazol Combix
If you interrupt treatment with Rabeprazol Combix
Relief of symptoms usually occurs before the ulcer has completely healed.
It is essential not to interrupt treatment until your doctor tells you to.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, Rabeprazol Combix may cause side effects, although
not everyone will experience them.
Side effects are usually mild and improve without you stopping treatment.
Stop taking Rabeprazol Combix and see your doctor immediately if you notice any of the following side effects – you may need urgent medical treatment:
These side effects are very rare (affect less than 1 in 10,000 people).
Other possible side effects;
Frequent (affect less than 1 in 10 people)
Rare (affect less than 1 in 100 people)
Rare (affect less than 1 in 1,000 people)
Other possible side effects (frequency unknown)
Do not worry about the list of side effects. You may not experience any of them.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of reach and sight of children.
Do not store at a temperature above 25°C.
Store in the outer packaging to protect it from moisture.
Do not use this medication after the expiration date shown on the packaging. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
Composition of Rabeprazol Combix 20 mg
The active ingredient is rabeprazole sodium. Each tablet contains 20 mg of rabeprazole sodium (equivalent to 18.85 mg of rabeprazole).
The other components are:core: povidone, mannitol (E421), light magnesium oxide, low-substituted hydroxypropyl cellulose, magnesium stearate;coating: ethyl cellulose, light magnesium oxide;enteric coating: ethyl acrylate-methacrylic acid copolymer, polysorbate 80, sodium lauryl sulfate, propylene glycol, talc, iron oxide red (E172), iron oxide yellow (E172), titanium dioxide (E171).
Appearance of the product and content of the container
Rabeprazol Combix 20 mg is presented as yellow-colored enteric-coated tablets in containers that contain aluminum blisters with the tablets housed in individual unit cells.
Rabeprazol Combix tablets are available in blisters containing 14, 28 tablets.
Only some container sizes may be commercially marketed.
Marketing authorization holder
Combix, S.L.U.
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Responsible for manufacturing
Balkanpharma Dupnitsa Ad
3 Samokovsko Shosse Str.
Dupnitsa
Bulgaria
Last review date of this leaflet: October 2022
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es.
The average price of Rabeprazol combix 20 mg comprimidos gastrorresistentes efg in July, 2025 is around 24.37 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.